Citadel Advisors - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269X955. A total of 3 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2016$120,000
-5.5%
33,800
-21.2%
0.00%
Q1 2016$127,000
-42.0%
42,900
-17.5%
0.00%
Q4 2015$219,000
+75.2%
52,000
+89.8%
0.00%
Q3 2015$125,000
+25.0%
27,400
+97.1%
0.00%
Q2 2015$100,000
-18.7%
13,900
-16.8%
0.00%
Q1 2015$123,000
+136.5%
16,700
+53.2%
0.00%
Q4 2014$52,000
+73.3%
10,900
+29.8%
0.00%
Q3 2014$30,000
-11.8%
8,400
+12.0%
0.00%
Q2 2014$34,000
-67.6%
7,500
-66.4%
0.00%
Q1 2014$105,000
+78.0%
22,300
+89.0%
0.00%
Q4 2013$59,00011,8000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,500$2,235,0000.12%
GROUP ONE TRADING, L.P. 602,200$5,384,0000.06%
SIMPLEX TRADING, LLC 862$46,0000.00%
JPMORGAN CHASE & CO 400,000$3,576,0000.00%
View complete list of ARRAY BIOPHARMA INC shareholders